Methods to measure compound specificity

摘要

A system is presented that uses a microassay which measures the activity of a tubulin ligand on mammalian brain (standard) and cancer cell (pathogen) tubulin, and by calculation of the Tubulin Ligand Index a comparison can be made as to the potency of the compound towards cancer cell tubulin and the potential to predict the efficacy of using compounds for cancer treatments.